RhythmONE vs Audifort 2026: Which Tinnitus Supplement Wins?
The short answer: RhythmONE and Audifort are targeting tinnitus from two mechanistically distinct angles. RhythmONE bets on the longevity pathway — that age-related mitochondrial decline and NAD+ depletion are significant upstream drivers of cochlear deterioration and tinnitus, and that activating SIRT1/NAD+ signaling via NMN, Resveratrol, and CoQ10 can slow or reverse this process. Audifort bets on the antioxidant-micronutrient pathway — that cochlear oxidative damage, impaired microcirculation, and correctable nutritional deficiencies (Zinc, Magnesium, B12) are the dominant mechanisms, and that addressing these with NAC, Ginkgo Biloba, and a micronutrient stack will reduce tinnitus severity. Both bets have legitimate scientific rationale. Your best choice depends on which mechanism is more relevant to your tinnitus pattern, age, and metabolic context.
TL;DR
- RhythmONE targets mitochondrial/cellular aging via NAD+ precursors (NMN), Resveratrol, and CoQ10 — best suited for age-related or metabolically-linked tinnitus, adults over 45, or those who have not responded to standard antioxidant approaches
- Audifort targets cochlear antioxidant status and micronutrient repletion via NAC, Ginkgo Biloba, ALA, Magnesium, and B12 — best suited for noise-induced, circulation-related, or nutritional-deficiency-driven tinnitus
- Both are priced at ~$69/bottle single, ~$49/bottle at the 6-pack tier, and carry 60-day money-back guarantees through ClickBank
- Audifort has significantly higher ClickBank gravity (66.6 vs RhythmONE’s 18), indicating broader market adoption and more established sales history
- For adults over 50 or those with metabolic aging concerns: RhythmONE’s longevity stack is mechanistically differentiated; for younger adults with noise exposure or nutritional deficits: Audifort is the better fit
| RhythmONE | Audifort | |
|---|---|---|
| Mechanism Focus | Mitochondrial longevity / NAD+ / SIRT1 | Cochlear antioxidant / microcirculation / micronutrient |
| Key Differentiator | NMN, Resveratrol, Vinpocetine | NAC (N-Acetyl Cysteine) |
| Price (1 bottle) | $69 | $69 |
| Best Bundle | 6-pack @ ~$49/bottle | 6-pack @ $49/bottle |
| Guarantee | 60-day money-back | 60-day money-back |
| ClickBank Gravity | 18 | 66.6 |
| Best For | Age-related / mitochondrial tinnitus | Noise-induced / nutritional-deficiency tinnitus |
| Dose Transparency | Partial | Full |
| Shared Ingredients | Ginkgo, ALA, CoQ10, Zinc, Mg, B12, B6 | Ginkgo, ALA, CoQ10, Zinc, Mg, B12, B6 |
Check Current RhythmONE Pricing on the Official Website{rel=“nofollow sponsored”} — 60-day money-back guarantee
Check Current Audifort Pricing on the Official Website{rel=“nofollow sponsored”} — 60-day money-back guarantee
1. Quick Comparison at a Glance
Before diving deep into mechanisms and clinical evidence, here is a comprehensive head-to-head summary across the most important decision criteria:
| Criterion | RhythmONE | Audifort | Edge |
|---|---|---|---|
| Primary Mechanism | Mitochondrial energy + longevity pathway (NAD+/SIRT1 activation) | Cochlear oxidative stress reduction + micronutrient correction | Depends on your tinnitus type |
| Key Unique Ingredients | NMN, Resveratrol, Vinpocetine | NAC (N-Acetyl Cysteine) | RhythmONE for longevity; Audifort for cochlear protection |
| Shared Ingredients | Ginkgo, ALA, CoQ10, Zinc, Mg, B12, B6 | Same | Tie |
| Best-Fit Buyer | Adults 45+, age-related hearing decline, metabolic or mitochondrial history | Noise exposure, circulation issues, known nutritional deficits | Situational |
| Clinical Evidence (formula) | Emerging NAD+/tinnitus literature; strong ingredient-level evidence | More direct tinnitus ingredient research; cochlear endpoint studies | Audifort (slight edge) |
| ClickBank Gravity | 18 | 66.6 | Audifort |
| Single Bottle Price | $69 | $69 | Tie |
| 3-Bottle Price | Tie | ||
| 6-Bottle Price | Tie | ||
| Shipping (US) | Free | Free | Tie |
| Refund Policy | 60-day money-back (ClickBank) | 60-day money-back (ClickBank) | Tie |
| Dose Transparency | Partial disclosure | Full milligram disclosure | Audifort |
| Manufacturing | GMP-certified facility | GMP-certified facility | Tie |
Bottom line from the table: The formulas are more similar than their branding suggests — both share seven ingredients and both build toward cochlear protection. The strategic difference is that RhythmONE extends upstream into the longevity signaling pathway (NAD+/SIRT1/Resveratrol) while Audifort adds NAC, the most specific cochlear antioxidant in either formula. Which layer matters more depends on the mechanism driving your tinnitus.
2. Mechanism Comparison: How Each Formula Works
Understanding the mechanism is the most important step in choosing between these two supplements. Tinnitus is not a single disease — it is a symptom produced by multiple overlapping pathophysiological pathways. Understanding what causes tinnitus is prerequisite to making an intelligent supplement choice.
RhythmONE: The Mitochondrial Longevity Pathway
RhythmONE’s core hypothesis is that age-related mitochondrial decline is an upstream cause of cochlear hair cell vulnerability, and that activating the longevity signaling pathways can slow or partially reverse this vulnerability — reducing tinnitus as a downstream result.
The biochemical logic centers on NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential to every mitochondrial energy-production reaction. NAD+ levels in human tissue decline approximately 50% between ages 40 and 70 — a well-documented finding across species. As NAD+ falls, mitochondrial energy output drops, cellular repair capacity diminishes, and reactive oxygen species accumulate faster than antioxidant defenses can clear them. In the cochlea — an organ with uniquely high metabolic demands and essentially no regenerative capacity — this progression means hair cells accumulate damage faster and die sooner than they would with optimal NAD+ status.
NMN (Nicotinamide Mononucleotide) is the NAD+ precursor RhythmONE relies on to restore declining NAD+ levels. NMN is absorbed and converted to NAD+ via the salvage pathway, bypassing the slower de novo synthesis route. A 2020 human RCT published in Cell Metabolism by Yoshino et al. demonstrated that oral NMN supplementation at 250mg/day safely raised blood NAD+ levels in postmenopausal women — the first proof-of-concept human trial confirming NMN’s NAD+-raising efficacy in humans. PMID 31955728. For cochlear health specifically, a 2022 animal model study demonstrated that NAD+ precursor supplementation could attenuate age-related cochlear hair cell loss and associated hearing threshold shifts. PMID 34654556
Resveratrol’s mechanism in RhythmONE operates through SIRT1 activation — Resveratrol is a well-characterized SIRT1 activator, and SIRT1 is one of the primary longevity-associated sirtuins that regulate mitochondrial biogenesis, oxidative stress response, and DNA repair. The SIRT1-NAD+ relationship is synergistic: SIRT1 activity depends on NAD+ availability, and raising NAD+ via NMN potentiates SIRT1’s protective effects. PMID 18787749. Resveratrol has also shown direct cochlear protective effects in animal models of noise-induced hearing loss, reducing hair cell death via both antioxidant and SIRT1-mediated mechanisms. PMID 27199085
CoQ10 (Coenzyme Q10) is a mitochondrial electron transport chain component essential for ATP production in cochlear hair cells. CoQ10 also functions as a lipid-phase antioxidant, protecting mitochondrial membranes from oxidative damage. As mitochondria age, CoQ10 biosynthesis declines — paralleling the NAD+ decline. One small clinical trial (Neri et al., 2009) demonstrated tinnitus improvement in patients with CoQ10 deficiency after 16 weeks of CoQ10 supplementation. PMID 17005327
Alpha Lipoic Acid (ALA) contributes a mitochondrial-specific antioxidant layer to RhythmONE. ALA scavenges reactive oxygen species in both aqueous and lipid cellular compartments and can regenerate other antioxidants (Vitamin C, Vitamin E, glutathione). Its mitochondrial targeting amplifies RhythmONE’s cellular energy theme. Pilot trial data suggested tinnitus improvement at higher ALA doses in some patients. PMID 17712993
Vinpocetine is RhythmONE’s most pharmacologically active differentiator. A semisynthetic derivative of Vincamine (from periwinkle), Vinpocetine inhibits PDE1 (phosphodiesterase-1) and voltage-gated sodium channels, producing cerebral vasodilation and improved cerebral blood flow. In the context of tinnitus, its primary value is cochlear and cerebral blood-flow augmentation — the same rationale as Ginkgo Biloba but via a different receptor mechanism. European clinical evidence has supported Vinpocetine for tinnitus associated with cerebrovascular insufficiency. PMID 8064502
The integrated RhythmONE mechanism: Restore NAD+ levels to reduce mitochondrial energy deficits in cochlear hair cells → activate SIRT1-mediated repair pathways via Resveratrol → support mitochondrial electron transport efficiency via CoQ10 and ALA → augment cochlear blood flow via Vinpocetine and Ginkgo → correct micronutrient deficiencies (Zinc, Magnesium, B12, B6) that elevate cochlear vulnerability. This is a coherent, layered strategy for the aging cochlea.
Audifort: The Cochlear Antioxidant Pathway
Audifort’s approach is more targeted: reduce oxidative stress in the cochlear environment, support the blood supply to cochlear hair cells, and correct nutritional deficiencies that measurably worsen cochlear function and tinnitus perception.
NAC (N-Acetyl-L-Cysteine) is Audifort’s most clinically relevant differentiator relative to RhythmONE. NAC is a glutathione precursor — it directly replenishes the cochlea’s primary endogenous antioxidant. In the cochlea, glutathione depletion following noise exposure is the primary driver of hair cell oxidative death. NAC administered before or shortly after noise exposure in animal models consistently reduced hair cell loss and preserved auditory thresholds. PMID 18180965. Human data from military and industrial noise exposure contexts are emerging. The cochlear-specificity of NAC’s mechanism of action makes it uniquely valuable for noise-induced tinnitus — and it is the ingredient that most clearly distinguishes Audifort from RhythmONE’s formula.
Ginkgo Biloba (EGb761) is the most studied botanical for tinnitus across both formulas. Standardized EGb761 extract at 120–240mg/day has been evaluated in multiple RCTs. A 2015 Cochrane systematic review found statistically significant improvement in tinnitus loudness with Ginkgo compared to placebo, though effect sizes were described as modest. PMID 26120122. The primary mechanism is cochlear microcirculation: Ginkgo flavonoids and terpenoids improve hemorheology and inhibit platelet-activating factor (PAF), increasing cochlear blood flow. Both formulas include Ginkgo — this is not a differentiator between them. For a thorough review of the evidence, Ginkgo Biloba for Tinnitus covers the clinical literature in detail.
Magnesium is Audifort’s strongest conventional mineral for cochlear protection. Magnesium acts as a cochlear vasodilator — it inhibits vasoconstrictor endothelin-1 activity and protects the stria vascularis from ischemia during noise exposure. The most compelling human data comes from a double-blind RCT in Israeli military conscripts: those receiving Magnesium supplementation during basic training showed significantly less noise-induced hearing loss than the placebo group. PMID 8642077. For the full clinical evidence review, see Magnesium and Tinnitus Evidence.
Alpha Lipoic Acid in Audifort functions similarly to its role in RhythmONE — as a broad-spectrum mitochondrial antioxidant in both aqueous and lipid phases. The formulas overlap here.
Vitamin B12 (Methylcobalamin) addresses a frequently underappreciated driver of tinnitus: B12 deficiency is disproportionately prevalent in tinnitus patients across multiple observational studies. Methylcobalamin — the neurologically active form used by Audifort — is essential for myelin maintenance in the auditory nerve. Demyelination from B12 deficiency creates auditory nerve conduction abnormalities that can generate or amplify tinnitus. PMID 8074948. The B Vitamins and Hearing Health guide covers this relationship in depth.
The integrated Audifort mechanism: Replenish glutathione antioxidant defense via NAC → reduce cochlear oxidative load via ALA → augment cochlear microcirculation via Ginkgo and Magnesium → correct auditory nerve demyelination risk via B12 → address Zinc and B6 deficiency contributions to cochlear vulnerability. This is a direct, evidence-supported approach to the most common cochlear tinnitus drivers.
For a broader primer on how both pathways operate in practice, the How Tinnitus Supplements Work guide covers the full mechanistic landscape.
3. Ingredient-by-Ingredient Comparison
This side-by-side table covers every known ingredient across both formulas. Both products overlap substantially — the differentiators are narrower than their branding implies.
| Ingredient | RhythmONE | Audifort | Clinical Evidence for Tinnitus / Hearing |
|---|---|---|---|
| NMN (Nicotinamide Mononucleotide) | ✓ (undisclosed mg) | ✗ | Raises NAD+ levels in human tissue — proven in 2020 RCT. Cochlear hair cell NAD+ decline is documented in aging; NMN precursor supplementation attenuated age-related cochlear loss in animal models. PMID 31955728, PMID 34654556 |
| Resveratrol | ✓ (undisclosed mg) | ✗ | SIRT1 activator. Cochlear protective effects via SIRT1 and antioxidant mechanisms in animal models of noise-induced hearing loss. PMID 27199085. Effective dose range in human trials: 100–500mg/day. |
| Vinpocetine | ✓ (undisclosed mg) | ✗ | Cerebral and cochlear vasodilator via PDE1 inhibition. Clinical evidence for tinnitus in cerebrovascular insufficiency contexts (European data). PMID 8064502 |
| NAC (N-Acetyl-L-Cysteine) | ✗ | ✓ 600mg | Glutathione precursor; strongest cochlear-specific antioxidant in either formula. Robust animal-model evidence for noise-induced cochlear protection. PMID 18180965 |
| Ginkgo Biloba Extract | ✓ (undisclosed mg) | ✓ 120mg | Most-studied botanical for tinnitus. EGb761 standardized extract shows statistically significant benefit vs. placebo in some RCTs; cochlear microcirculation mechanism. PMID 26120122 |
| CoQ10 | ✓ (undisclosed mg) | ✓ 100mg | Mitochondrial ATP production and lipid-phase antioxidant. Small clinical trial showed tinnitus improvement in CoQ10-deficient patients. PMID 17005327 |
| Alpha Lipoic Acid | ✓ (undisclosed mg) | ✓ 200mg | Mitochondrial antioxidant (aqueous + lipid); pilot tinnitus trial data at higher doses (400–800mg). PMID 17712993 |
| Magnesium Glycinate | ✓ (undisclosed mg) | ✓ 100mg | Cochlear vasodilator; strongest RCT evidence of any mineral for noise-induced hearing loss prevention. PMID 8642077 |
| Zinc | ✓ (undisclosed mg) | ✓ 15mg | Deficiency independently associated with tinnitus severity. Supplementation in zinc-deficient patients improves tinnitus in some trials. PMID 12544024 Full review: Zinc Deficiency and Ear Health. |
| Vitamin B12 (Methylcobalamin) | ✓ (undisclosed mg) | ✓ 500mcg | B12 deficiency associated with tinnitus; methylcobalamin supports auditory nerve myelin. PMID 8074948 |
| Vitamin B6 (Pyridoxine) | ✓ (undisclosed mg) | ✓ 10mg | GABA biosynthesis cofactor; general neurotransmitter synthesis; auditory pathway support. Deficiency elevates auditory sensitivity. |
What the ingredient table reveals:
The overlap (7 shared ingredients) is more striking than the differences. Both formulas are building toward the same cochlear protection goal using a largely identical antioxidant-and-micronutrient backbone. The differentiation is real but narrower than the product branding suggests:
- RhythmONE’s unique layer: NAD+/mitochondrial longevity (NMN + Resveratrol + SIRT1 activation) plus vascular augmentation via Vinpocetine. This represents a genuine upstream extension of the standard cochlear antioxidant approach.
- Audifort’s unique layer: NAC, the most cochlear-specific antioxidant compound in either formula, directly addressing glutathione depletion in the cochlear perilymph — the primary mechanism of noise-induced hair cell death.
If you are choosing primarily on differentiated ingredients rather than shared backbone, the comparison reduces to: NMN + Resveratrol (longevity pathway) vs. NAC (cochlear-specific antioxidant). Which matters more depends on whether your tinnitus is primarily age/metabolic in origin (RhythmONE’s differentiator matters more) or noise/oxidative in origin (Audifort’s differentiator matters more).
4. What’s Unique to Each Formula
RhythmONE’s Exclusive Ingredients
NMN (Nicotinamide Mononucleotide) is RhythmONE’s most novel ingredient and its strongest intellectual claim to differentiation. NAD+ decline with age is not a theoretical hypothesis — it is one of the most replicated findings in geroscience, documented by David Sinclair’s lab at Harvard, the Guarente lab at MIT, and multiple independent research groups. The cochlear relevance is direct: stria vascularis cells and spiral ganglion neurons have high metabolic rates and depend on robust mitochondrial function; NAD+ decline impairs this function and accelerates vulnerability to acoustic and oxidative damage. Restoring NAD+ via NMN theoretically addresses a root cause of age-related cochlear decline rather than only managing downstream damage. The RhythmONE Side Effects and Ingredients analysis covers NMN’s clinical evidence and dosing in full detail.
Resveratrol is the second longevity-pathway compound unique to RhythmONE. Its SIRT1 activation mechanism is synergistic with NMN — raising NAD+ (via NMN) gives SIRT1 the substrate it needs to function, and Resveratrol amplifies SIRT1 activity. Animal studies have shown that Resveratrol protects cochlear hair cells from noise-induced apoptosis through both SIRT1-mediated DNA repair and direct antioxidant mechanisms. The effective dose range in human longevity research (100–500mg/day) is meaningful for cochlear benefit — but without RhythmONE disclosing its specific dose, verifying whether it reaches this threshold is not possible from public information.
Vinpocetine is the most pharmacologically active of RhythmONE’s exclusive ingredients. Unlike most botanical vasodilators, Vinpocetine has a defined receptor mechanism (PDE1 inhibition → cAMP/cGMP elevation → smooth muscle relaxation → vasodilation) and has been used as a pharmaceutical drug in Europe and Asia for cerebrovascular insufficiency for decades. For tinnitus specifically, Vinpocetine’s cochlear blood-flow augmentation adds a distinct vasodilatory mechanism on top of the formula’s antioxidant stack. It is particularly relevant for tinnitus with a vascular or circulatory component — pulsatile tinnitus, tinnitus associated with neck tension, or tinnitus that fluctuates with blood pressure changes.
Audifort’s Exclusive Ingredient
NAC (N-Acetyl-L-Cysteine) at 600mg is Audifort’s clinically strongest differentiator. It is not merely an antioxidant — it is a cysteine donor that directly feeds the cochlea’s own antioxidant manufacturing process (the glutathione synthesis pathway). The cochlear significance is well-established in animal models: NAC administered prophylactically or acutely after noise exposure significantly reduces cochlear hair cell death in multiple species. Audifort’s decision to include 600mg of NAC — at the lower end of the studied therapeutic range for cochlear protection, but within it — is the single most cochlear-targeted ingredient decision across both formulas.
For users whose tinnitus followed a specific noise event (concert, gunshot, occupational exposure), NAC’s mechanism is more directly relevant than RhythmONE’s longevity stack. Conversely, for users whose tinnitus developed gradually with age without a specific acoustic event, RhythmONE’s NMN/Resveratrol approach targets a more likely upstream cause.
5. Clinical Evidence Comparison
This section grades the research quality behind each formula’s core mechanism. Neither product has been tested as a finished formula in a human tinnitus RCT — both are extrapolating from ingredient-level evidence.
RhythmONE’s Evidence Base
| Mechanism / Ingredient | Evidence Quality | Key Finding |
|---|---|---|
| NAD+ decline with age | ★★★★★ | Replicated across species and tissues; one of geroscience’s most robust findings |
| NMN raises NAD+ in humans | ★★★★☆ | 2020 human RCT confirmed NAD+ elevation from oral NMN; more trials ongoing |
| NAD+ precursors protect cochlear hair cells | ★★★☆☆ | Animal model evidence; no human cochlear tinnitus trials yet |
| Resveratrol / SIRT1 cochlear protection | ★★★☆☆ | Animal model protection from noise-induced hearing loss; human tinnitus trials absent |
| Vinpocetine for cochlear blood flow | ★★★☆☆ | Clinical use in Europe; European tinnitus trial data supportive; not FDA-approved |
| CoQ10 for tinnitus | ★★★☆☆ | One positive small trial in CoQ10-deficient patients |
| Ginkgo Biloba for tinnitus | ★★★★☆ | Multiple RCTs; Cochrane review found statistically significant but modest effect |
| Shared micronutrients (Zn, Mg, B12, B6) | ★★★★☆ | Strong observational + some RCT evidence for deficiency-correction benefit |
Overall RhythmONE evidence assessment: Strong mechanistic rationale with robust foundational science (NAD+ decline, SIRT1 biology), but thin direct evidence for tinnitus outcomes in humans. The formula is built on credible but upstream science — the evidence chain from “NAD+ supports mitochondrial function” to “NMN supplementation reduces tinnitus in humans” has several unconfirmed links. This is the limitation of a longevity-science approach applied to a specific symptom that has not yet been studied in longevity-framework RCTs.
Audifort’s Evidence Base
| Mechanism / Ingredient | Evidence Quality | Key Finding |
|---|---|---|
| NAC for cochlear oxidative protection | ★★★★☆ | Robust animal-model data; human pilot trials emerging |
| Ginkgo Biloba for tinnitus | ★★★★☆ | Cochrane-reviewed; statistically significant but modest effect |
| Magnesium for noise-induced hearing loss | ★★★★★ | Human RCT in military personnel; most robust mineral finding in either formula |
| B12 deficiency and tinnitus | ★★★★☆ | Strong observational association; supplementation benefit in deficient patients |
| Zinc deficiency and tinnitus | ★★★☆☆ | Observational association; supplementation benefit limited to deficient patients |
| Alpha Lipoic Acid for tinnitus | ★★☆☆☆ | Single pilot trial with positive signal; effect size uncertain |
| CoQ10 for tinnitus | ★★★☆☆ | Same evidence as RhythmONE — one positive small trial in deficient patients |
Overall Audifort evidence assessment: Better direct tinnitus-endpoint coverage at the ingredient level. Magnesium has the single strongest human tinnitus-related evidence across both formulas. NAC has the strongest cochlear mechanism evidence. The evidence chain from ingredient to cochlear outcome is shorter — fewer extrapolation steps between “NAC prevents noise-induced glutathione depletion” and “NAC may support cochlear health in humans” than between “NMN raises NAD+” and “tinnitus is improved.”
Honest verdict: Audifort’s evidence base is more directly connected to tinnitus outcomes. RhythmONE’s is more scientifically ambitious — betting that upstream longevity signaling will produce cochlear benefits — but that bet relies on longer evidence chains. Both remain dietary supplements without FDA approval for any tinnitus claim. Neither has been tested as a finished formula in a human RCT.
6. Price and Value Comparison
Both products use the standard ClickBank multi-bottle pricing structure. Here is a full breakdown across all tiers:
| Bundle | RhythmONE | Audifort |
|---|---|---|
| 1 bottle (30-day supply) | $69 | $69 |
| 3 bottles (90-day supply) | ||
| 6 bottles (180-day supply) | ||
| Shipping (US) | Free | Free |
| Guarantee | 60-day money-back | 60-day money-back |
| Purchase channel | Official website only | Official website only |
| Daily cost (6-bottle tier) | ~$1.63 | ~$1.63 |
Pricing is functionally identical at every tier — this is a common feature of ClickBank supplement vendors that operates in the same price corridor. It means cost should not be a deciding factor between these two products. The mechanistic fit is the relevant differentiator.
90-day trial note: Both the manufacturer positioning and the ClickBank supplement industry standard suggest a minimum 90-day commitment (3-bottle tier) for fair evaluation of any dietary supplement in this category. This is consistent with the supplement’s mechanism — mitochondrial restoration (RhythmONE) and nutritional repletion (Audifort) both require sustained daily supplementation to reach their effects. Buying a single bottle and evaluating at 30 days does not give either formula a fair test. The 3-bottle bundle is the minimum recommended starting point.
Guarantee mechanics: Both guarantees operate through ClickBank’s buyer protection infrastructure. This is substantively different from a vendor-only guarantee. ClickBank’s buyer support can independently initiate refunds if vendor customer service fails to respond — making the 60-day money-back guarantee a genuine consumer protection backed by a third-party payment processor, not merely a marketing claim. For full pricing details and current promotional offers, the RhythmONE Pricing and Discount Guide is kept current with bundle availability.
Experience RhythmONE for Yourself — 60-Day Guarantee
RhythmONE’s longevity-focused formula is backed by a full 60-day money-back guarantee through ClickBank. If you try it for 90 days and notice no change in your tinnitus or hearing quality, contact support before day 60 for a complete refund — no questions asked.
Visit RhythmONE Official Website — Risk-Free with 60-Day Money-Back Guarantee{rel=“nofollow sponsored”}
7. User Profile: Who Should Choose RhythmONE?
RhythmONE is the better-fit choice for users in the following specific situations:
Adults over 45 with gradual-onset tinnitus — if your tinnitus did not follow a specific noise event but developed gradually over years, and if your overall hearing has declined progressively with age, the mitochondrial aging pathway is the most likely upstream driver. RhythmONE’s NAD+/NMN/Resveratrol stack targets exactly this mechanism. Age-related cochlear hair cell loss (presbycusis) is by definition a mitochondrial aging process — the cochlea ages faster than most tissues because it cannot regenerate and its metabolic demands never cease.
Users who have already tried standard antioxidant supplements without improvement — if you have used Ginkgo Biloba, Alpha Lipoic Acid, or Magnesium supplementation for 90+ days without meaningful tinnitus improvement, adding the same ingredients via Audifort is unlikely to produce different results. RhythmONE’s NMN and Resveratrol represent a genuinely different mechanistic layer that Audifort does not provide. For users who have exhausted the standard cochlear antioxidant approach, RhythmONE’s longevity stack is worth exploring.
Users interested in the longevity science angle — if you are already aware of the NAD+/NMN research literature (David Sinclair’s work, the Guarente lab’s findings, the hallmarks-of-aging framework), RhythmONE’s formula is explicitly built from that framework applied to cochlear biology. This is the only major ClickBank tinnitus supplement to incorporate NMN and the SIRT1-activation approach, making it a genuinely novel entry in the category.
Users with vascular or circulatory tinnitus characteristics — if your tinnitus is pulsatile (rhythmic, synchronous with heartbeat), varies with head position or neck tension, or is associated with poor circulation generally, RhythmONE’s Vinpocetine component adds a mechanistically relevant cerebrovascular vasodilator. No other mainstream tinnitus supplement includes Vinpocetine.
Users who are comfortable with partial dose disclosure — RhythmONE does not publicly disclose specific milligram quantities for most of its proprietary ingredients. For users who prioritize trying a novel formula and are comfortable trusting the overall mechanistic rationale, this is acceptable. For users who want to cross-reference every ingredient dose against published clinical trials, this is a limitation. The RhythmONE Review 2026 covers the full formula analysis with available dose information.
Metabolically conscious supplement users — if you already supplement with NMN or Resveratrol for general longevity reasons, RhythmONE represents a cochlear-targeted version of that stack — consolidating longevity ingredients with hearing-specific compounds in a single formula.
8. User Profile: Who Should Choose Audifort?
Audifort is the better-fit choice for users in these specific situations:
Noise-induced tinnitus — if your tinnitus began following a specific acoustic event (concert, firearm use, occupational noise exposure, acoustic trauma, military service), NAC’s glutathione-replenishing mechanism is the most directly relevant cochlear protection compound available in either formula. RhythmONE does not contain NAC; Audifort does. For this specific tinnitus etiology, Audifort is the more mechanistically appropriate starting point.
Adults under 45 without metabolic aging context — the longevity-pathway argument is most compelling when mitochondrial aging is a significant factor — typically more relevant from the late 40s onward. For adults under 45 whose tinnitus is likely noise-induced or nutritional in origin rather than mitochondrial aging-driven, Audifort’s cochlear antioxidant and micronutrient approach is more age-appropriate.
Users with documented nutritional deficiencies — if lab work has confirmed low Magnesium intake (true for over 45% of Americans based on NHANES dietary data), B12 deficiency (common in adults over 50, vegans, vegetarians, and metformin users), or zinc deficiency (common with poor dietary variety), Audifort’s micronutrient panel directly corrects these deficiencies. Nutritional repletion for a documented deficiency is among the most evidence-supported approaches in the entire supplement category.
Users who prioritize dose transparency — Audifort discloses all ingredient doses on its supplement facts panel. You can verify that its Ginkgo Biloba (120mg) is at the lower end of the studied clinical range, its NAC (600mg) is within the therapeutic range, its B12 (500mcg) is the neurologically active methylcobalamin form, and so on. This verification is not possible with RhythmONE’s proprietary blend structure. Research-oriented users who want to independently evaluate what they are taking will find Audifort’s transparency meaningful. For the full independent review, Audifort Review 2026 covers 90 days of personal testing and complete clinical analysis.
First-time tinnitus supplement users — Audifort’s higher ClickBank gravity (66.6) reflects broader market validation. For someone approaching the tinnitus supplement category for the first time and uncertain about which formula to start with, Audifort represents the category’s most established performer — with broader real-world feedback, more extensive marketing testing, and a longer consumer track record. When in doubt, a higher-gravity established product is the lower-risk starting point.
Users with cochlear hearing loss confirmed by audiometry — if an audiologist has documented cochlear-pattern hearing loss alongside tinnitus (particularly high-frequency sensorineural pattern), the cochlear oxidative stress and microcirculation model is the most applicable pathophysiological explanation. Audifort’s formula is calibrated for exactly this presentation.
If you are also considering other formulas in the hearing category, the Audifort vs. Quietum Plus comparison and Zeneara Review provide additional positioning context across the Wave-1 hearing supplement cluster.
9. Can You Trust Both Brands?
Legitimacy Signals: RhythmONE
RhythmONE is sold via ClickBank (Vendor: Rhythmoneprotocol) with a ClickBank gravity score of 18. A gravity of 18 is in the active-and-converting range for a product that has been on the market for a shorter period or that targets a more specific niche demographic. Gravity in this range is not indicative of a scam — it reflects a real product with real sales converting through the ClickBank affiliate network. Products with fraudulent claims or zero consumer value do not sustain gravity above 5–10 because affiliates stop promoting them when refund rates exceed acceptable thresholds.
The 60-day money-back guarantee is enforced through ClickBank’s third-party buyer protection system. This is the most important legitimacy signal for any ClickBank supplement: the refund mechanism does not depend on the vendor’s good faith, because ClickBank’s own buyer support will initiate chargebacks if vendors fail to respond.
Manufacturing: RhythmONE states GMP-certified facility production — the same industry standard applicable to any reputable US supplement brand. FDA registration of the manufacturing facility means GMP compliance is verified by third-party audit, not vendor self-attestation.
Legitimacy Signals: Audifort
Audifort’s ClickBank gravity of 66.6 is among the strongest in the hearing supplement category and represents sustained market performance over time. Gravity is calculated on a rolling recent-period basis — a product cannot maintain gravity above 50+ on reputation alone; it requires ongoing sales velocity, acceptable refund rates, and active affiliate promotion. Audifort’s gravity suggests it has maintained all three over a meaningful period.
Audifort’s full dose transparency on the supplement facts panel is itself a trust signal — proprietary blending without disclosure is legal but allows manufacturers to list ingredients at cosmetic rather than therapeutic doses. Audifort’s disclosed doses (120mg Ginkgo, 600mg NAC, 200mg ALA, 100mg CoQ10) are at or near the lower end of clinical trial ranges, suggesting the formula was designed to meet clinical dosing standards rather than marketing minimums.
Both brands are manufactured in GMP-certified facilities, sold exclusively through official websites (not Amazon third-party), and backed by ClickBank’s enforceable 60-day guarantee. Neither exhibits scam indicators (auto-recurring billing without disclosure, missing contact information, no refund mechanism). The relevant question between these two products is clinical fit and formulation philosophy, not legitimacy.
10. Our Final Recommendation
This comparison comes down to one diagnostic question: what is driving your tinnitus?
If your tinnitus developed gradually with age, has no specific noise-event origin, has been present for years without a clear audiological explanation, and if you are over 45 — RhythmONE is the mechanistically differentiated choice for your situation. No other mainstream tinnitus supplement targets the NAD+/mitochondrial longevity pathway with RhythmONE’s specificity. The evidence chain from NMN → NAD+ restoration → cochlear hair cell protection is scientifically credible, built on replicable geroscience research, and represents a genuinely upstream intervention rather than downstream damage management. Vinpocetine adds a vasodilatory layer that no other hearing supplement includes. If the standard antioxidant-micronutrient approach (which Audifort represents at high quality) has already been tried without benefit, RhythmONE’s longevity angle is the logical next investigative step.
If your tinnitus followed noise exposure, is associated with documented cochlear-pattern hearing loss, or you have known nutritional deficiencies in Magnesium, B12, or Zinc — Audifort is the stronger choice for your pattern. Its NAC content is the most cochlear-specific antioxidant compound in either formula, its dose transparency allows independent clinical verification, and its gravity of 66.6 represents the most validated market performance in the hearing supplement category. For first-time supplement users uncertain where to start, Audifort is the more established and broadly-evidenced default.
For the undecided buyer: Both formulas share seven ingredients and are priced identically. The key distinction is one layer of uniqueness in each direction — RhythmONE extends upstream into longevity signaling (NMN, Resveratrol, Vinpocetine) and Audifort adds the most cochlear-specific antioxidant (NAC). Both carry the same 60-day money-back guarantee, making trial cost zero if the formula does not fit your situation. The financially rational approach: choose based on the etiology question above, commit to 90 days with honest baseline documentation, and use the money-back window as genuine consumer protection if the formula underperforms.
Neither product cures tinnitus. Neither replaces audiological evaluation if your tinnitus is new, progressive, unilateral, or accompanied by sudden hearing loss. Both are dietary supplements that may support cochlear health as part of a broader approach that includes audiological assessment, hearing protection practice, noise management, and appropriate medical workup.
Get RhythmONE Now — Risk-Free with 60-Day Money-Back Guarantee
RhythmONE combines NMN, Resveratrol, CoQ10, Vinpocetine, and Ginkgo Biloba in a longevity-focused formula built for age-related cochlear support. Try it risk-free — if it’s not the right fit for your tinnitus pattern, the 60-day money-back guarantee means you can request a full refund with no questions asked.
Visit the Official RhythmONE Website{rel=“nofollow sponsored”}
Frequently Asked Questions
Which is better: RhythmONE or Audifort?
It depends on your tinnitus profile. RhythmONE’s longevity-focused formula (NAD+, Resveratrol, CoQ10) targets mitochondrial decline and age-related cellular energy deficits — making it most suitable for older adults or those with tinnitus linked to metabolic or age-related hearing changes. Audifort’s antioxidant-micronutrient formula (NAC, ALA, Zinc, B12) targets oxidative cochlear damage and nutritional deficiency patterns. Both have 60-day guarantees, making trial risk low.
Do RhythmONE and Audifort contain the same ingredients?
There is meaningful overlap — both contain Ginkgo Biloba, Alpha Lipoic Acid, CoQ10, Zinc, Magnesium, B12, and B6. RhythmONE differentiates with NAD+ precursors (NMN), Resveratrol, and Vinpocetine. Audifort differentiates with NAC (N-Acetyl-L-Cysteine), which has specific cochlear antioxidant evidence. The longevity compounds are RhythmONE’s unique value proposition.
Which is cheaper, RhythmONE or Audifort?
Both are priced identically at every tier — $69 single bottle, approximately $59/bottle at the 3-pack, and approximately $49/bottle at the 6-pack. Pricing is not a meaningful differentiator between these two products. Choose based on formula fit, not cost.
Can I take RhythmONE and Audifort together?
We do not recommend stacking these products without healthcare provider guidance. Both formulas contain overlapping ingredients (Zinc, Magnesium, B12, B6, Ginkgo Biloba), and taking both simultaneously risks exceeding safe upper intake levels for some nutrients, particularly Zinc (the tolerable upper intake level is 40mg/day for adults). Choose one and commit to a 90-day trial before evaluating whether to add or switch.
Which tinnitus supplement has a better track record?
Audifort has a ClickBank gravity score of 66.6, indicating a longer track record and higher sustained sales volume relative to RhythmONE’s 18. More established products generally have more verifiable customer feedback. RhythmONE is a newer entrant with growing early momentum, a distinct formulation angle, and the same ClickBank consumer protection. Gravity reflects market performance — not necessarily clinical superiority.
Is RhythmONE safe to take?
RhythmONE’s ingredients are generally well-tolerated at nutritional and supplemental doses. Specific considerations: Resveratrol may have mild antiplatelet activity at higher doses — relevant for users on blood thinners; Vinpocetine should be used cautiously during pregnancy and may interact with anticoagulants; Ginkgo Biloba carries antiplatelet caution for users on aspirin, warfarin, or NSAIDs. NMN is well-tolerated in human trials at studied doses. For a full interaction and safety analysis, RhythmONE Side Effects and Ingredients covers the complete profile.
Where can I buy RhythmONE and Audifort?
Both products are sold exclusively through their respective official websites via the ClickBank platform. Neither is available on Amazon, Walmart, or in physical retail locations. Purchasing from any third-party listing risks counterfeit product and voids the ClickBank money-back guarantee. Always purchase through the official ClickBank checkout.
Try Audifort Risk-Free for 60 Days
Audifort’s cochlear antioxidant formula — with full dose transparency, the category’s highest ClickBank gravity, and a 60-day money-back guarantee — is the established choice for noise-induced or nutritional-deficiency tinnitus. See current pricing and bundle options on the official site.
Check Current Audifort Pricing on the Official Website{rel=“nofollow sponsored”}
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.